Pune, India — (PRESS RELEASE JET) — 09/28/2017 — Global eye allergy treatment market information, by type (seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, and others), by treatment (medication, medication, allergy shots, and others), by end user- forecast till 2023

Market Scenario: Eye allergies are one of the most common health problems across the globe. Approximately 50 million people have some or the other kind of eye allergy in US alone. Some of the common eye allergy symptoms are redness, itching, and burning. Increasing prevalence of various eye allergies are key driver for the market while some other factors like increasing awareness, technological advancements, new therapies, and increasing healthcare expenditure are also major driving forces of global eye allergy treatment market. The global eye allergy treatment market is expected to grow at the CAGR of ~5.2% during the forecast period and estimated to reach US$ 6845.3million by 2023.

Get a sample report at https://www.marketresearchfuture.com/sample_request/3811 .

Market Highlights The global eye allergy treatment market has been evaluated as a moderately growing market and it is expected to continue growing in the near future. Increasing prevalence of various eye allergies, development of advanced diagnostic and treatment devices, increasing adoption of new products and therapies, and new FDA and other approvals are driving the market. The market for eye allergy treatment was around USD 4800.5 million in 2016 and is expected to reach USD 6845.3 million which is projected to grow at a CAGR of 5.2% by 2023. Top pharmaceutical companies are dominating this market due to various factors such as strong global presence, sales and distribution network, investment in R&D, high quality products, and strong brand image. In 2016, Irish pharmaceutical giant Shire received U S Food and Drug Administration (FDA) approval for their dry-eye disease drug, this drug is marketed under the brand name Xiidra. Key companies to watch out for: Bausch & Lomb Incorporated is focusing on expansion of its product portfolio. In 2015, the company acquired ophthalmic diagnostic startup Doctor’s Allergy Formula. This diagnostic system is used by more than 1500 ophthalmologists.

Regional Analysis: Considering the global scenario of the eye allergy treatment market. America is top revenue generator in global market that is mainly due to some factors like new FDA approvals, aggressive strategies by pharmaceutical companies, increasing investment for R&D as well as clinical trials. European market is the second largest market for eye allergy treatment. Increasing prevalence and growing awareness of eye allergies and its treatments are leading the growth of Asia Pacific eye allergy treatment market. Middle East and Africa eye allergy treatment market is expected to have limited growth because of lack of traditional healthcare practices and slow adoption of new products and therapies. Segmentation: Global Eye Allergy Treatment market has been segmented on the basis of type which comprises of seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, contact allergic conjunctivitis, giant papillary conjunctivitis, and others. Vernal keratoconjunctivitis includes palpebral, limbal, corneal, and others. On the basis of treatment, the market has been segmented into medication, allergy shots (immunotherapy), and others. Medication includes artificial tears, decongestants, oral antihistamines, antihistamine/mast-cell stabilizers, corticosteroids. Decongestants are further sub-segmented into with or without antihistamines. Allergy shots (immunotherapy) is sub-segmented into Subcutaneous Immunotherapy Treatment (SCIT) and Sublingual Immunotherapy Treatment (SLIT). On the basis of end user, it is segmented into eye hospitals & clinics, medical institutes, research centers, and others.

Browse complete report at https://www.marketresearchfuture.com/reports/eye-allergy-treatment-market-3811 .

Study objectives of global Eye Allergy Treatment market: – To provide detailed analysis of the global eye allergy treatment market structure with historical and forecast revenue for the next six years of the various segments and sub-segments. – To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global eye allergy treatment market – To provide analysis of the market with respect to four main geographies and their countries – the Americas, Europe, Asia-Pacific, and Middle East & Africa. – To provide detailed analysis of the market segmented by type, treatment, end user, and its sub-segments. – To provide a detailed analysis of global eye allergy treatment market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc. – To provide a detailed country level analysis of the market with respect to the current market size and future prospects. – To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global eye allergy treatment market. – To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the eye allergy treatment market.

Key players for global eye allergy treatment market: Some of the key players in this market are: ALLERGAN (Republic of Ireland), Johnson & Johnson Vision Care, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), Regeneron Pharmaceuticals, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Santen Pharmaceutical Co., Ltd.(Japan), Valeant (Canada) Shire (Republic of Ireland), and others.

The report for Global Eye Allergy Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Powered by WPeMatico